O-Desethyl Dabigatran Etexilate with CAS No: 212321-78-3 is an impurity standard of Dabigatran. Dabigatran is an anticoagulant medication belonging to the class of direct thrombin inhibitors. Structurally, it is a competitive and reversible inhibitor of thrombin, a key enzyme in the blood coagulation cascade. Administered orally, dabigatran is prescribed for the prevention of stroke and systemic embolism in individuals with atrial fibrillation. It is also used for the treatment and prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE) following hip or knee replacement surgery. Dabigatran offers an alternative to traditional anticoagulants like warfarin and does not require frequent monitoring of coagulation parameters. Its targeted inhibition of thrombin plays a crucial role in preventing excessive blood clot formation. Buy high quality O-Desethyl Dabigatran Etexilate from Chemicea Pharmaceuticals. Chemicea Pharmaceuticals is one of the leading manufacturer and exporter of O-Desethyl Dabigatran Etexilate
Synonyms:
Desethyl Dabigatran Etexilate; Etexilate Acid Impurity; Desethyl Pradaxa; Dabigatran Etexilate EP Impurity E
Chemical Name:
3-[2-[[4-[N′-[(hexyloxy)carbonyl]carbamimidoyl]anilino]methyl]-1-methyl-N-(pyridin-2-yl)-1H-benzimidazole-5-carboxamido]propanoic acid (as per EP)
Request for Quotation : O-Desethyl Dabigatran Etexilate
Search by Keywords - Buy 212321-78-3 | Purchase 212321-78-3 | Order 212321-78-3 | Enquire 212321-78-3 | Price of 212321-78-3 | 212321-78-3 Cost | 212321-78-3 Supplier | 212321-78-3 Distributor | 212321-78-3 Manufacturer | 212321-78-3 Exporter | O-Desethyl Dabigatran Etexilate for Method Validation | O-Desethyl Dabigatran Etexilate for ANDA Filing | O-Desethyl Dabigatran Etexilate for Forced Degradation Studies | O-Desethyl Dabigatran Etexilate Identification Standards | O-Desethyl Dabigatran Etexilate for DMF Filing | Dabigatran
We have received your request successfully. Thank you for your interest in our product line. To
provide you with a Quotation, Our Sales team will contact you shortly.
Chemicea Pharmaceuticals Pvt. Ltd.
Thank You
You will receive blog content, featuring scientific research and exclusive promotions.